Medicare open enrollment has begun, introducing several significant changes to health and prescription drug coverage for 2027. Beneficiaries may face higher Part D cost thresholds and new pricing for certain medications. The enrollment period started on October 15 and will run through December 7. During this time, beneficiaries can compare their current plans with options like original Medicare, Medicare Advantage plans, and prescription drug plans. Selections made during this period will take effect on January 1.
Changes in Medicare Part D
In 2027, the Medicare Part D out-of-pocket threshold will increase to $2,400. The temporary program to stabilize standalone Part D premiums will end. Negotiated prices for 15 additional high-cost drugs will also take effect.
Reasons for Change
Medicare plans often adjust their premiums, provider networks, and cost-sharing requirements yearly. Staying with the same policy doesn’t guarantee identical coverage. Some beneficiaries will have higher prescription drug costs. Certain Medicare Advantage insurers plan to withdraw from some areas and reduce benefits. Meanwhile, Social Security recipients will receive a 3.6% cost-of-living adjustment in 2027, potentially adding $75 to the average monthly benefit. However, increasing healthcare costs might offset this gain.
Impact on Medicare Part D Costs
The rise in prescription drug spending marks a significant change. Medicare’s Part D out-of-pocket cap will increase from $2,100 in 2026 to $2,400 in 2027, causing beneficiaries with high prescription costs to spend more before reaching the annual limit. The standard Part D deductible will rise from $615 to $700. Kevin Thompson, CEO of 9i Capital Group, noted these increases could negate some benefits of the Social Security COLA.
Medicare Part D Premium Program Ends
The Centers for Medicare & Medicaid Services (CMS) will discontinue the Part D Premium Stabilization Demonstration at year-end, citing insurers’ experience in setting bids under the new benefits. As subsidies expire, some seniors might see slight premium increases, though these will vary by plan. The national base beneficiary premium for 2027 is set at $41.33, providing a base for calculating plan-specific premiums. A premium cap from the Inflation Reduction Act remains effective, limiting increases to 6% annually through 2029.
New Drug Prices Under Negotiation
In 2027, Medicare beneficiaries may see reduced prescription costs due to negotiated prices on 15 more drugs. Included are medications like Ozempic, Rybelsus, and Wegovy. According to CMS, these negotiated prices could lower out-of-pocket costs by $685 million in 2027.
Alterations in Medicare Advantage Plans
Beyond nationwide changes, some Medicare Advantage beneficiaries might experience significant modifications in 2027. Some insurers will pull plans from certain areas or reduce supplemental benefits such as dental coverage. Alex Beene at the University of Tennessee advises seniors to review coverage carefully due to potential premium hikes and benefit losses.
Enrollment Considerations
Beneficiaries should evaluate monthly premiums carefully, as well as any changes in their current plan’s premiums. Drug deductibles and copays will impact affordability amid raised Part D thresholds. Supplemental benefits like dental coverage might be reduced.
The Medicare open enrollment period concludes on December 7, with new coverage typically starting January 1. Seniors are encouraged to take action and consider these changes thoroughly to align their choices with needs and circumstances.
Leave a Reply